Objective Carotid intima-media thickness (IMT) is a useful surrogate marker of cardiovascular disease. In addition to low-density lipoprotein cholesterol (LDL-C), metabolic syndrome has been linked to the pathogenesis of atherosclerosis. The present study investigated whether the clustering of multiple components of metabolic syndrome has a greater impact on vascular parameters than individual components of metabolic syndrome, and assessed the association between carotid IMT and LDL-C and metabolic syndrome.
Introduction
The metabolic syndrome is defined as the clustering of several cardiovascular risk factors in an individual including visceral obesity, hypertension (HT), hypertriglyceridemia, low high-density lipoprotein cholesterolemia, and impaired glucose tolerance (1, 2) . Epidemiologic studies have shown that metabolic syndrome is quite common, affecting 13.3 24.4% of Japanese men > = 30 years of age (3, 4) , and that it is a predictor of adverse cardiovascular events (5) (6) (7) (8) . Several other metabolic disorders have also been associated with this syndrome, including microalbuminuria, and abnormalities in fibrinolysis and coagulation (9, 10) .
Carotid intima-media thickness (IMT) is a useful surrogate marker of cardiovascular disease and can now be measured noninvasively by B-mode ultrasonography. Several studies have shown close associations between this parameter and conventional cardiovascular risk factors, including age, obesity, smoking, HT, dyslipidemia including lowdensity lipoprotein cholesterol (LDL-C), and diabetes mellitus (DM) (11, 12) . However, the association between carotid IMT and LDL-C and metabolic syndrome have not been well studied.
In the present study, we examined whether the clustering of multiple components of metabolic syndrome has a greater impact on vascular parameters than individual components of metabolic syndrome, and investigated the association between carotid IMT and LDL-C and metabolic syndrome currently defined as visceral obesity and at least 2 of the 3 following conditions: HT, dyslipidemia and impaired fasting glucose.
Participants were consecutively enrolled from in-patients in the medical department of Seiyo Municipal Nomura Hospital between August 1996 and March 2005. Patients with a clinical history of cerebrovascular disease or present neurological abnormalities, cerebral hemorrhage and severe cardio-renal or nutritional disorders that would affect blood pressure, lipid and glucose metabolism were excluded.
Seven hundred sixty patients were enrolled in the study. The subjects consisted of 340 men aged 64±16 (mean±stan-dard deviation) years and 420 women aged 69±13 years. The causes of hospitalization of the participants were respiratory disorders including pneumonia in 208 cases, DM in 168, digestive disorders in 110, neurological disorders other than stroke in 81, infections in 57, urinary or reproductive organ disorders in 28, mental disorders in 23, HT in 20, collagen or skin disorders in 19, metabolic disorders in 16, hematological disorders in 6, peripheral vascular disorders in 4, benign neoplasm in 1 and miscellaneous diseases in 19. Informed consent for the procedure was obtained from each patient. All procedures were approved by the Ethics Committee of Seiyo Municipal Nomura Hospital.
Evaluation of risk factors
Information on demographic characteristics and risk factors were collected using the clinical files in all cases. We measured blood pressure in the right upper arm of patients in a sedentary posture using a standard sphygmomanometer or an automatic oscillometric blood pressure recorder. We defined a smoker as a subject with a pack-year index >0 (packyear was defined as packs of cigarettes per day multiplied by years smoked). Total cholesterol (T-C), triglyceride (TG) and high-density lipoprotein cholesterol (HDL-C) were measured under a fasting condition within 24 hours after admission. LDL-C level was calculated by the Friedewald formula (13) , and patients with TG levels > = 400 mg/dl were excluded. History of anti-hypertensive and anti-lipidemic drug use was also evaluated.
Ultrasound image analysis
An ultrasonograph (Hitachi EUB-565 or Aloka SSD-2000) equipped with a 7.5 MHz linear type B-mode probe was used by a specialist in ultrasonography to evaluate sclerotic lesions of the common carotid arteries on a day close to the day of blood biochemistry analysis (within 2 days). Patients were asked to assume a supine position, and the bilateral carotid arteries were observed obliquely from the anterior and posterior directions. We measured the thickness of the IMT on the far wall of the bilateral common carotid artery about 10 mm proximal to the bifurcation of the carotid artery (as the image at that site is more clearly depicted than that at the near wall) (14, 15) as well as wall thickness near the 10 mm point on B-mode monitor. We then used the mean value for analysis.
Regarding the measurement of fat thickness by ultrasonographic evaluation (Hitachi EUB-565 or Aloka SSD-2000) using a 7.5 MHz linear type B-mode probe, the subjects were placed in the supine position, the probe was held perpendicular to the skin at the epigastrium, and vertical scanning was performed along the abdominal median from the processus xiphoideus to the umbilicus to measure the maximal thickness of preperitoneal fat (Pmax) at the anterior surface of the liver (16) .
Metabolic syndrome
We applied condition-specific cut-off points for metabolic syndrome based on the guidelines for diagnosis of 'metabolic syndrome' in Japan (17) . Metabolic syndrome was defined as visceral obesity assessed by ultrasonography and at least 2 of the following 3 conditions: HT, dyslipidemia (hypertriglycedemia or low HDL cholesterolemia) and impaired fasting glucose.
Visceral obesity was shown by Pmax > = 6.9 mm in men or > = 10 mm in women (equal to visceral fat accumulation > = 100 cm 2 as measured by computed tomography) (18) . Hypertension was defined as systolic blood pressure (SBP) > = 130 mmHg or diastolic blood pressure (DBP) > = 85 mmHg or those who had been treated for HT. Hypertriglycedemia was identified based on TG concentrations > = 150 mg/dl. Low HDL cholesterolemia was identified by an HDL-C <40 mg/dl, or those who had been treated for dyslipidemia. Impaired fasting glucose was defined as fasting plasma glucose > = 110 mg/dl, or those who had been treated for DM.
Statistical analysis
All values are expressed as mean ± standard deviation (SD), unless otherwise specified. Statistical analysis was performed using SPSS 10.0J (Statistical Package for Social Science, Inc., Chicago, IL, USA). The prevalence among control subjects and metabolic syndrome patients was compared by 2 test. Differences among groups were analyzed by the Mann-Whitney U-test or Kruskal-Wallis test. A multiple regression model was employed to evaluate the significance of confounding risk factors and metabolic syndrome for carotid IMT. The relation between carotid atherosclerosis (IMT > = 1.0 mm) (15) and risk factors were examined by logistic multiple regression analysis. A value of p<0.05 was considered significant.
Results
Background of subjects Table 1 Metabolic Syndrome and Carotid Atherosclerosis metabolic syndrome were significantly higher in patients with carotid atherosclerosis than in those without carotid atherosclerosis, but the HDL-C was significantly lower in subjects with carotid atherosclerosis. The prevalence of metabolic syndrome using the modified National Cholesterol Education Program's Adult Treatment Panel III report (NCEP-ATP III), that is, the presence of at least 3 of the following abnormalities: visceral obesity; HT; hypertriglyceridemia; low HDL-cholesterolemia and impaired fasting glucose, was 29.8% in those without carotid atherosclerosis and 50.2% in those with carotid atherosclerosis. Moreover, the prevalence of metabolic syndrome using the 2005 Japanese criteria was 24.7% and 39.5%, respectively.
Distribution of carotid atherosclerosis by number of metabolic syndrome component conditions in those with and without visceral obesity
The degree and distribution of carotid atherosclerosis by number of metabolic syndrome component conditions (CC) according to the presence/absence of visceral obesity are shown in Table 2 . The carotid IMT were significantly greater in those with a CC number > = 2 than those with CC < = 1 (p<0.001) in both subjects with and without visceral obesity. On 2 test, the frequency of IMT > = 1.0 mm or plaque + stenosis was significantly higher in those with a CC number > = 2 (p<0.001). Then, carotid IMT increased with increasing number of metabolic syndrome components in both subjects with and without visceral obesity (p for trend <0.001). Carotid IMT in each number of these component conditions did not differ significantly between the two groups ( Fig. 1) .
Metabolic syndrome and conventional risk factors for carotid atherosclerosis
Pearson's correlation coefficient and multiple regression analysis were performed to evaluate the independent contribution of each factor to carotid IMT. As shown in Table 3 , age, smoking status, SBP, DBP, prevalence of anti-hypertensive drug use, HDL-C, LDL-C, history of DM and prevalence of metabolic syndrome were significantly correlated with carotid IMT, and age, male sex, smoking status, SBP, HDL-C, LDL-C, history of DM and prevalence of metabolic syndrome were significantly independently associated with carotid IMT.
Odds ratio of carotid atherosclerosis associated with metabolic syndrome
Using 2 test, we also analyzed the risk of carotid atherosclerosis in relation to the presence of metabolic syndrome and different component conditions of the syndrome (Table 4 ). In the syndrome model, the unadjusted odds ratio (OR) 95% confidence interval (CI) for metabolic syndrome and elevated LDL-C (> = 130 mg/dl) were 2.00 (1.45-2.76) and 2.10 (1.48-2.99), respectively. In the component model, the unadjusted OR (95% CI) for visceral obesity, HT, dyslipidemia and impaired fasting glucose were 1.27 (0.94-1.72), 3.28 (2.28-4.71), 1.65 (1.21-2.25) and 1.41 (1.03-1.94), respectively. Moreover, for each disease definition, 2 models after adjustment for age (> = 75 years), male sex, 
Odds ratio of atherothrombotic infarction associated with metabolic syndrome
Multiple logistic regression analysis for carotid atherosclerosis was performed using sex, age, obesity, smoking, DM and presence/absence of metabolic syndrome as variables by quartiles of LDL-C in these subjects (Fig. 2 ). An increased risk for carotid atherosclerosis was associated with increases in quartile of LDL-C in subjects with and without metabolic syndrome. Compared to those without metabolic syndrome, subjects with metabolic syndrome after adjustment for covariates showed a higher odds ratio.
Disucussion
Metabolic syndrome, representing a cluster of insulin resistance, visceral obesity, HT, dyslipidemia, glucose intolerance, is a common basis for the development of atherosclerosis, especially coronary heart disease and atherosclerotic brain infarction (5-8). In our study, metabolic syndrome was present in 38.5% of men and 22.5% of women. Importantly, metabolic syndrome was associated with an independently increased risk for carotid atherosclerosis after taking into account each individual component of metabolic syndrome. Furthermore, metabolic syndrome and elevated LDL-C seem to play a role in accelerating this age-associated process.
In the present study, we tentatively defined metabolic syndrome using the 2005 Japanese criteria (17), which have been appropriately adjusted for the Japanese population. In this criteria, visceral obesity is defined as an important and necessary risk factor, differing from NCEP-ATP III criteria (2), in which visceral obesity is defined as one of five risk factors. Moreover, obesity is frequently accompanied by dyslipidemia, HT, and glucose intolerance, however it has been shown that BMI is not associated with carotid atherosclerosis in our studies (20, 21 .4) p<0.001** relationship has been demonstrated in recent studies in which regional adiposity of the upper body was more closely associated with atherosclerosis incidence than the magnitude of generalized obesity (22, 23) . Then, we used Pmax > = 6.9 mm in men or > = 10 mm in women by ultrasonography (18) as the cut-off point for visceral obesity. It has been reported that Metabolic syndrome was defined as visceral obesity and at least 2 of the 3 following conditions: hypertension, dyslipidemia (low HDL cholesterolemia or/and hypertriglyceridemia), and impaired fasting glucose. § Smoking status: daily consumption (packs)×duration of smoking (years).
† Body mass index was calculated using weight in kilograms divided by the square of the height in meters.
‡ Visceral obesity was shown by Pmax > = 6.9 mm in men or > = 10 mm in women. R 2 , multiple coefficient of determination. each Pmax value was equal to visceral fat accumulation > = 100 cm 2 measured by computed tomography, which was defined as visceral adiposity in the 2005 Japanese criteria (17). Our finding, however, supported the concept that accumulation of adiposity has been shown to be unimportant as a marker of carotid atherosclerosis (24) (25) (26) . These findings have demonstrated that recent metabolic disorder induced by a history of obesity is an important factor in atherosclerosis. It is, indeed, reported that maximum BMI as a history of obesity was significantly correlated with IMT thickening (27) .
The clinical importance of metabolic syndrome is related to its putative impact on carotid atherosclerosis. As shown in Fig. 1 , as the degree of risk factors for metabolic syndrome increased, carotid IMT also increased. In the progression of atherosclerosis, metabolic syndrome was markedly associated with positive remodeling of the common carotid artery. In the multivariate model of our study including the metabolic syndrome components as variables, metabolic syndrome and LDL-C as well as age, smoking status and DM were significantly associated with carotid atherosclerosis. Furthermore, of the component conditions of metabolic syndrome, HT and dyslipidemia were associated with an elevated risk of carotid atherosclerosis. Scuteri et al (28) also reported that metabolic syndrome is independently associated with an increased IMT and stiffness adjusted for established risk factors as well as each component of metabolic syndrome. This suggests that the components of MS interact to synergistically impact vascular thickness and remodeling. Our data support the conclusion that a focus on the coexistence of multiple abnormalities allows one to identify a large number of subjects at risk of atherosclerosis progression who would be missed with a focus limited to single abnormalities (26) .
There have been several Japanese epidemiologic studies; an association between carotid atherosclerosis and several components of metabolic syndrome, as observed in the present study, has been reported in another study (12) . In these studies, multiple regression analysis found independent relationships between carotid atherosclerosis and age, male sex, HT, LDL-C, HDL-C, and history of DM. The unique findings of the present study are that subjects with metabolic syndrome identified by clinically applicable criteria showed an independent association with LDL-C to influence on carotid IMT. Hulthe et al (29) reported that subjects with metabolic syndrome had an increased carotid IMT compared to that of subjects with no risk factors, and components of the metabolic syndrome such as insulin resistance, dyslipidemia, and glucose intolerance are significantly associated with increasing LDL-C (30) and also related to small LDL particles (31) (32) (33) . In addition, LDL-C (12) and small LDL particle sizes are also associated with the occurrence and size of plaques in the carotid artery (29) . These suggest that the components of MS and LDL-C play a role to synergistically impact vascular thickness.
We need to be aware of limitations in interpreting the present results. Based on its cross-sectional study design, the present result is inherently limited in its ability to eliminate causal relationships between risk factors and carotid atherosclerosis. Since all participants were hospitalized patients, we could not eliminate the possible effects of underlying diseases on the IMT findings. We also could not eliminate the possible effect of medication for HT and dyslipidemia on the present findings. Anti-hypertensive drug use varied from 27.4% in those without carotid atherosclerosis to 41.1% in those with carotid atherosclerosis. However, such an effect is unlikely because only 3.0% of subjects without carotid atherosclerosis and 3.2% of those with carotid atherosclerosis received lipid-lowering treatment. Secondary prevention interventions after obesity, HT, dyslipidemia and DM may be successful in reducing risk factors, thus attenuating the observed association of risk factors with disease. These points need to be addressed again using a large population-based sample in a prospective fashion.
In summary, we reported a significant association between the clustering of cardiovascular risk factors called metabolic syndrome and carotid IMT in subjects with risk factors for atherosclerosis. Furthermore, metabolic syndrome and LDL-C as well as age, male sex, smoking status and DM were significantly associated with carotid atherosclerosis. This syndrome confers an increased risk of cardiovascular morbidity, and its identification may thus be important in risk assessment and treatment of patients. 
